Table S1.
Demographics and clinical characteristics of the study population at baseline and at the end of 3-month therapy
| Patients (n=47)
|
Obese group (n= 32)
|
Nonobese group (n=15)
|
||||
|---|---|---|---|---|---|---|
| Baseline | End | Baseline | End | Baseline | End | |
| Age | 52±10.2 | – | 50.5±10.6 | – | 55.2±8.9 | – |
| Gender | ||||||
| Men | 25 | 25 | 14 | 14 | 11 | 11 |
| Women | 22 | 22 | 18 | 18 | 4 | 4 |
| BMI (kg/m2) | 32.32±5.6 | 32.8±5.9 | 35.2±4.4 | 35.7±4.9 | 26.2±1.8 | 26.7±1.8 |
| Weight (kg) | 89.9±17.3 | 91.4±18.5** | 96.3±17.1 | 97.7±18.6* | 76.4±7.5 | 77.9±8.1 |
| Systolic blood pressure (mmHg) | 128.5±12.8 | 135±14.5*** | 130.1±13.2 | 136.9±14.5** | 125±11.4 | 130.8±13.9 |
| Diastolic blood pressure (mmHg) | 70.5±12 | 72±15.9 | 70.6±12.8 | 71.4±17.5 | 70.3±10.5 | 73.3±12.1 |
| Heart rate | 83.9±10.5 | 83.5±12.8 | 83.4±11.3 | 84.8±11.4 | 85±8.7 | 80.6±15.4 |
| Creatinine (μmol/L) | 73.5±14.6 | 76.6±20.2 | 72±13.2 | 76.1±20.9 | 76.7±17.4 | 77.5±19 |
| eGFR (mL/min/1.73m2) | 88.6±17.1 | 85.5±19.9 | 89.3±17.1 | 84.9±20.2* | 87.2±17.8 | 86.7±19.8 |
Notes: Values are mean ± SD.
*
p-value between baseline and end. Creatinine (Cr) normal level: 71–115 (μmol/L).
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate.